| Epivir Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Epivir 150 mg | tablet | oral | 1.0 each | OTC |
| Epivir 300 mg | tablet | oral | 1.0 each | OTC |
| Epivir 10 mg/mL | solution | oral | 1.0 milliliter(s) | OTC |
Posted by aprilscrazy over 6 years ago
leg and feet pains
Both 3TC and tenofovir have high concentrations in female genital ... - Aidsmap
all 2 news articles
Mon Feb 18 06:26:45 -0500 2008
Merck’s Isentress Could Hold Promise for Several Patient Populations - FDA news (subscription)
An ongoing Phase II study in treatment-naive patients is comparing Isentress in combination with Viread (tenofovir disoproxil fumarate) and Epivir ...
Thu Feb 14 17:39:38 -0500 2008
Amdoxovir plus Zidovudine Demonstrates Potent Antiviral Activity ... - PharmaLive.com (press release)
Retrovir, Ziagen and Epivir are registered trademarks of GlaxoSmithKline. Videx is a registered trademark of Bristol-Myers Squibb. ...
Thu Feb 07 09:38:39 -0500 2008
lamivudine - A synthetic nucleoside analogue with activity against hepatitis B virus (HBV) and HIV. Intracellularly, lamivudine is phosphorylated to its active metabolites, lamiduvine triphosphate (L-TP) and lamiduvine monophosphate (L-MP). In HIV, L-TP inhibits HIV-1 reverse transcriptase (RT) via DNA chain termination after incorporation of the nucleoside analogue into viral DNA. In HBV, incorporation of L-MP into viral DNA by HBV polymerase results in DNA chain termination. L-TP is a weak inhibitor of mammalian DNA polymerases alpha and beta, and mitochondrial DNA polymerase. (NCI04)